Preparation method of recombinant panda IL-2 immune adjuvant
An IL-2, immune adjuvant technology, applied in the biological field, can solve the problems of poor safety, unsatisfactory vaccines, and low immune efficiency
Inactive Publication Date: 2014-01-15
四川卧龙国家级自然保护区管理局 +1
View PDF0 Cites 5 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Vaccine immunization is currently the main measure to prevent and control CDV, but the vaccines currently used are not very ideal, and there are two major problems of low immunization efficiency and poor safety
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0052] The present invention will be described in detail below in conjunction with specific embodiments.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention discloses a preparation method of a recombinant panda IL-2 immune adjuvant. The recombinant panda IL-2 immune adjuvant is a recombinant panda IL-2 (gpIL-2) immune adjuvant, which has a prominent effect and a convenient extraction process, can be directly applied to production and clinical application, improves the immune effect of canine distemper vaccine strain and other conventional vaccines, controls the occurrence and epidemic of diseases, and protects the health of panda. Canine distemper is usually known as "the fatal infectious disease", has become the first fulminating infectious disease that threatens the species number and life safety of pandas, and badly affects the healthy development of pandas. The recombinant panda IL-2 (gpIL-2) immune adjuvant can prominently strengthen the immune effect of canine distemper vaccine strain, and has an important meaning on preventing and treating of canine distemper.
Description
technical field [0001] The invention relates to the field of biotechnology, in particular to a preparation method of a recombinant giant panda IL-2 (gpIL-2) immune adjuvant. Background technique [0002] The giant panda is known as China's "national treasure" and is a world-class rare wild animal. However, it is on the verge of extinction. In addition to the destruction of the giant panda's habitat due to human factors, disease and death have become one of the key reasons for the current endangered giant panda population. Among the more than 40 kinds of diseases that giant pandas suffer from, canine distemper is the most severe infectious disease that threatens the population and life safety of giant pandas. Vaccine immunization is currently the main measure to prevent and control CDV, but the vaccines currently used are not very ideal, and there are two problems of low immunization efficiency and poor safety. Therefore, improving the immunity of giant pandas under safe dos...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/70A61K39/39
Inventor 李德生朱玲张和民王承东易悦刘骁
Owner 四川卧龙国家级自然保护区管理局
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com